The FY2024 (Dec) proxy of Ironwood Pharmaceuticals names 17 peer companies for pay. Pay versus performance data of Ironwood Pharmaceuticals for that year is not on file, so it has no rank.
Pay peer group, FY2024 (Dec) proxy
| Supernus Pharmaceuticals | ||
| Pacira BioSciences | ||
| Ultragenyx Pharmaceutical | ||
| Halozyme Therapeutics | ||
| INSMED | ||
| Alkermes plc. | ||
| Acadia Pharmaceuticals | ||
| PTC Therapeutics | ||
| Mirum Pharmaceuticals | ||
| Travere Therapeutics | ||
| Amicus Therapeutics, Inc. | Not disclosed | Not disclosed |
| Ardelyx | Not disclosed | Not disclosed |
| Biocryst Pharmaceuticals | Not disclosed | Not disclosed |
| Blueprint Medicines Corporation | Not disclosed | Not disclosed |
| Corcept Therapeutics | Not disclosed | Not disclosed |
| Dynavax Technologies Corporation | Not disclosed | Not disclosed |
| Ligand Pharmaceuticals | Not disclosed | Not disclosed |
17 companies
PSU comparator group
The companies that relative total shareholder return is measured against for performance stock units.
| United Therapeutics | ||
| TG Therapeutics | ||
| Supernus Pharmaceuticals | ||
| Incyte | ||
| Pacira BioSciences | ||
| Krystal Biotech | ||
| Ionis Pharmaceuticals | ||
| Ultragenyx Pharmaceutical | ||
| Halozyme Therapeutics | ||
| INSMED | ||
| Alkermes plc. | ||
| Mannkind | ||
| Neurocrine Biosciences | ||
| Adma Biologics | ||
| Acadia Pharmaceuticals | ||
| PTC Therapeutics | ||
| Agios Pharmaceuticals | ||
| Mirum Pharmaceuticals | ||
| Travere Therapeutics | ||
| Vanda Pharmaceuticals | ||
| Sarepta Therapeutics | ||
| Amicus Therapeutics, Inc. | Not disclosed | Not disclosed |
| Apellis Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Ardelyx | Not disclosed | Not disclosed |
| Biocryst Pharmaceuticals | Not disclosed | Not disclosed |
| Blueprint Medicines Corporation | Not disclosed | Not disclosed |
| Catalyst Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Coherus BioSciences, Inc. | Not disclosed | Not disclosed |
| Corcept Therapeutics | Not disclosed | Not disclosed |
| Deciphera Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Dynavax Technologies Corporation | Not disclosed | Not disclosed |
| Exelixis | Not disclosed | Not disclosed |
| ImmunoGen, Inc. | Not disclosed | Not disclosed |
| Ligand Pharmaceuticals | Not disclosed | Not disclosed |
| Macrogenics | Not disclosed | Not disclosed |
| Mirati Therapeutics, Inc. | Not disclosed | Not disclosed |
| Organogenesis Holdings | Not disclosed | Not disclosed |
| Rhythm Pharmaceuticals | Not disclosed | Not disclosed |
| Sage Therapeutics, Inc. | Not disclosed | Not disclosed |
| Vericel | Not disclosed | Not disclosed |
40 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.